Tuesday, May 06, 2025

Training | 2022.02.03

Biom Pharmaceuticals’ Antiviral Compound Bi121 Shows Broad-spectrum Activity Against Three Variants of SARS-CoV-2

Biom Pharmaceuticals announced today that the preclinical studies of antiviral preparation Bi121 showed significant antiviral activity against various strains of SARS-CoV-2.

(PRWeb February 03, 2022)

Read the full story at https://www.prweb.com/releases/biom_pharmaceuticals_antiviral_compound_bi121_shows_broad_spectrum_activity_against_three_variants_of_sars_cov_2/prweb18475667.htm

 

For more information, please visit
https://www.prweb.com/releases/biom_phar[...]f_sars_cov_2/prweb18475667.htm

You need to login to post comments.

Feed last updated 2024/10/31 @10:10 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News